Copyright Reports & Markets. All rights reserved.

Global Radiology Drug Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Radiology Drug Therapy
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Radiology Drug Therapy by Type
    • 1.3.1 Overview: Global Radiology Drug Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Radiology Drug Therapy Consumption Value Market Share by Type in 2022
    • 1.3.3 Oncology
    • 1.3.4 Cardiology
    • 1.3.5 Others
  • 1.4 Global Radiology Drug Therapy Market by Application
    • 1.4.1 Overview: Global Radiology Drug Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospitals
    • 1.4.3 Academic & Research Institutes
    • 1.4.4 Others
  • 1.5 Global Radiology Drug Therapy Market Size & Forecast
  • 1.6 Global Radiology Drug Therapy Market Size and Forecast by Region
    • 1.6.1 Global Radiology Drug Therapy Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Radiology Drug Therapy Market Size by Region, (2018-2029)
    • 1.6.3 North America Radiology Drug Therapy Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Radiology Drug Therapy Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Radiology Drug Therapy Market Size and Prospect (2018-2029)
    • 1.6.6 South America Radiology Drug Therapy Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Radiology Drug Therapy Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Nihon Medi-Physics
    • 2.1.1 Nihon Medi-Physics Details
    • 2.1.2 Nihon Medi-Physics Major Business
    • 2.1.3 Nihon Medi-Physics Radiology Drug Therapy Product and Solutions
    • 2.1.4 Nihon Medi-Physics Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Nihon Medi-Physics Recent Developments and Future Plans
  • 2.2 ITM Isotopen Technologien München AG
    • 2.2.1 ITM Isotopen Technologien München AG Details
    • 2.2.2 ITM Isotopen Technologien München AG Major Business
    • 2.2.3 ITM Isotopen Technologien München AG Radiology Drug Therapy Product and Solutions
    • 2.2.4 ITM Isotopen Technologien München AG Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 ITM Isotopen Technologien München AG Recent Developments and Future Plans
  • 2.3 Advanced Accelerator Applications
    • 2.3.1 Advanced Accelerator Applications Details
    • 2.3.2 Advanced Accelerator Applications Major Business
    • 2.3.3 Advanced Accelerator Applications Radiology Drug Therapy Product and Solutions
    • 2.3.4 Advanced Accelerator Applications Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Advanced Accelerator Applications Recent Developments and Future Plans
  • 2.4 Telix Pharmaceuticals
    • 2.4.1 Telix Pharmaceuticals Details
    • 2.4.2 Telix Pharmaceuticals Major Business
    • 2.4.3 Telix Pharmaceuticals Radiology Drug Therapy Product and Solutions
    • 2.4.4 Telix Pharmaceuticals Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Telix Pharmaceuticals Recent Developments and Future Plans
  • 2.5 GE Healthcare
    • 2.5.1 GE Healthcare Details
    • 2.5.2 GE Healthcare Major Business
    • 2.5.3 GE Healthcare Radiology Drug Therapy Product and Solutions
    • 2.5.4 GE Healthcare Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 GE Healthcare Recent Developments and Future Plans
  • 2.6 Theragnostics Ltd.
    • 2.6.1 Theragnostics Ltd. Details
    • 2.6.2 Theragnostics Ltd. Major Business
    • 2.6.3 Theragnostics Ltd. Radiology Drug Therapy Product and Solutions
    • 2.6.4 Theragnostics Ltd. Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Theragnostics Ltd. Recent Developments and Future Plans
  • 2.7 NuView Life Sciences
    • 2.7.1 NuView Life Sciences Details
    • 2.7.2 NuView Life Sciences Major Business
    • 2.7.3 NuView Life Sciences Radiology Drug Therapy Product and Solutions
    • 2.7.4 NuView Life Sciences Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 NuView Life Sciences Recent Developments and Future Plans
  • 2.8 Jubilant Pharma Limited
    • 2.8.1 Jubilant Pharma Limited Details
    • 2.8.2 Jubilant Pharma Limited Major Business
    • 2.8.3 Jubilant Pharma Limited Radiology Drug Therapy Product and Solutions
    • 2.8.4 Jubilant Pharma Limited Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Jubilant Pharma Limited Recent Developments and Future Plans
  • 2.9 Lantheus Holdings, Inc.
    • 2.9.1 Lantheus Holdings, Inc. Details
    • 2.9.2 Lantheus Holdings, Inc. Major Business
    • 2.9.3 Lantheus Holdings, Inc. Radiology Drug Therapy Product and Solutions
    • 2.9.4 Lantheus Holdings, Inc. Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Lantheus Holdings, Inc. Recent Developments and Future Plans
  • 2.10 Curium Pharma
    • 2.10.1 Curium Pharma Details
    • 2.10.2 Curium Pharma Major Business
    • 2.10.3 Curium Pharma Radiology Drug Therapy Product and Solutions
    • 2.10.4 Curium Pharma Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Curium Pharma Recent Developments and Future Plans
  • 2.11 Bayer AG
    • 2.11.1 Bayer AG Details
    • 2.11.2 Bayer AG Major Business
    • 2.11.3 Bayer AG Radiology Drug Therapy Product and Solutions
    • 2.11.4 Bayer AG Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Bayer AG Recent Developments and Future Plans
  • 2.12 Clarity Pharmaceuticals
    • 2.12.1 Clarity Pharmaceuticals Details
    • 2.12.2 Clarity Pharmaceuticals Major Business
    • 2.12.3 Clarity Pharmaceuticals Radiology Drug Therapy Product and Solutions
    • 2.12.4 Clarity Pharmaceuticals Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Clarity Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Radiology Drug Therapy Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Radiology Drug Therapy by Company Revenue
    • 3.2.2 Top 3 Radiology Drug Therapy Players Market Share in 2022
    • 3.2.3 Top 6 Radiology Drug Therapy Players Market Share in 2022
  • 3.3 Radiology Drug Therapy Market: Overall Company Footprint Analysis
    • 3.3.1 Radiology Drug Therapy Market: Region Footprint
    • 3.3.2 Radiology Drug Therapy Market: Company Product Type Footprint
    • 3.3.3 Radiology Drug Therapy Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Radiology Drug Therapy Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Radiology Drug Therapy Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Radiology Drug Therapy Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Radiology Drug Therapy Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Radiology Drug Therapy Consumption Value by Type (2018-2029)
  • 6.2 North America Radiology Drug Therapy Consumption Value by Application (2018-2029)
  • 6.3 North America Radiology Drug Therapy Market Size by Country
    • 6.3.1 North America Radiology Drug Therapy Consumption Value by Country (2018-2029)
    • 6.3.2 United States Radiology Drug Therapy Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Radiology Drug Therapy Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Radiology Drug Therapy Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Radiology Drug Therapy Consumption Value by Type (2018-2029)
  • 7.2 Europe Radiology Drug Therapy Consumption Value by Application (2018-2029)
  • 7.3 Europe Radiology Drug Therapy Market Size by Country
    • 7.3.1 Europe Radiology Drug Therapy Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Radiology Drug Therapy Market Size and Forecast (2018-2029)
    • 7.3.3 France Radiology Drug Therapy Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Radiology Drug Therapy Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Radiology Drug Therapy Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Radiology Drug Therapy Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Radiology Drug Therapy Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Radiology Drug Therapy Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Radiology Drug Therapy Market Size by Region
    • 8.3.1 Asia-Pacific Radiology Drug Therapy Consumption Value by Region (2018-2029)
    • 8.3.2 China Radiology Drug Therapy Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Radiology Drug Therapy Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Radiology Drug Therapy Market Size and Forecast (2018-2029)
    • 8.3.5 India Radiology Drug Therapy Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Radiology Drug Therapy Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Radiology Drug Therapy Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Radiology Drug Therapy Consumption Value by Type (2018-2029)
  • 9.2 South America Radiology Drug Therapy Consumption Value by Application (2018-2029)
  • 9.3 South America Radiology Drug Therapy Market Size by Country
    • 9.3.1 South America Radiology Drug Therapy Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Radiology Drug Therapy Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Radiology Drug Therapy Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Radiology Drug Therapy Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Radiology Drug Therapy Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Radiology Drug Therapy Market Size by Country
    • 10.3.1 Middle East & Africa Radiology Drug Therapy Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Radiology Drug Therapy Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Radiology Drug Therapy Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Radiology Drug Therapy Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Radiology Drug Therapy Market Drivers
  • 11.2 Radiology Drug Therapy Market Restraints
  • 11.3 Radiology Drug Therapy Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Radiology Drug Therapy Industry Chain
  • 12.2 Radiology Drug Therapy Upstream Analysis
  • 12.3 Radiology Drug Therapy Midstream Analysis
  • 12.4 Radiology Drug Therapy Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Radiology Drug Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumors, such as thyroid tumors, lymphomas, or bone metastases, to deliver radiation to neoplastic lesions as part of a therapeutic strategy to cure, alleviate, or control the disease.
    This report is a detailed and comprehensive analysis for global Radiology Drug Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Radiology Drug Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
    Global Radiology Drug Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
    Global Radiology Drug Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
    Global Radiology Drug Therapy market shares of main players, in revenue ($ Million), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Radiology Drug Therapy
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Radiology Drug Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nihon Medi-Physics, ITM Isotopen Technologien München AG, Advanced Accelerator Applications, Telix Pharmaceuticals and GE Healthcare, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market segmentation
    Radiology Drug Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Oncology
    Cardiology
    Others
    Market segment by Application
    Hospitals
    Academic & Research Institutes
    Others
    Market segment by players, this report covers
    Nihon Medi-Physics
    ITM Isotopen Technologien München AG
    Advanced Accelerator Applications
    Telix Pharmaceuticals
    GE Healthcare
    Theragnostics Ltd.
    NuView Life Sciences
    Jubilant Pharma Limited
    Lantheus Holdings, Inc.
    Curium Pharma
    Bayer AG
    Clarity Pharmaceuticals
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Radiology Drug Therapy product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Radiology Drug Therapy, with revenue, gross margin and global market share of Radiology Drug Therapy from 2018 to 2023.
    Chapter 3, the Radiology Drug Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Radiology Drug Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
    Chapter 12, the key raw materials and key suppliers, and industry chain of Radiology Drug Therapy.
    Chapter 13, to describe Radiology Drug Therapy research findings and conclusion.

    Buy now